19. November 2009 10:45
Advanced Cell Technology, Inc. announced today that it filed an Investigational New Drug (IND) Application with the US Food and Drug Administration (FDA) to initiate a Phase I/II multicenter study using embryonic stem cell derived retinal cells to treat patients with Stargardt’s Macular Dystrophy (SMD). Among the most common causes of untreatable blindness in the world are degenerative diseases of the retina.
[More]
19. November 2009 06:30
Visually impaired people appear to be fearless, navigating busy sidewalks and crosswalks, safely finding their way using nothing more than a cane as a guide. The reason they can do this, researchers suggest, is that in at least some circumstances, blindness can heighten other senses, helping individuals adapt.
[More]
19. November 2009 04:37
SoloHealth (www.solo-health.com), maker of EyeSite™ self-service vision testing and self-directed healthcare kiosks, has teamed with Atlanta area Kroger stores to promote eye health awareness and to encourage regular eye exams.
[More]
18. November 2009 10:31
Millennium: The Takeda Oncology Company today announced it has further expanded its protein homeostasis program with the initiation of a Phase I clinical trial for an oral formulation of MLN9708, the Company’s second-generation proteasome inhibitor. An intravenous formulation of MLN9708 entered clinical trials in March.
[More]
a61a65ac-e150-48dc-bb4d-d91e79fc3c1c|0|.0
Posted in: Drug Trial News | Medical Condition News
Tags: Abdominal Pain, Anemia, Anorexia, Anxiety, Arthralgia, Blindness, Bone, Cancer, Cell, Constipation, Cough, Dehydration, Diarrhea, Doxorubicin, Dyspnea, Edema, Headache, Heart Failure, Herpes, Herpes Zoster, Hypersensitivity, Insomnia, Liposome, Lymphoma, Multiple Myeloma, Nausea, Neuropathy, Neutropenia, Nursing, Oncology, Peripheral Neuropathy, Pneumonia, Thrombocytopenia, Ubiquitin, Vomiting
18. November 2009 06:58
Research and Markets (http://www.researchandmarkets.com/research/4e2e61/ophthalmic_pharmac) has announced the addition of the "Ophthalmic Pharmaceutical Drugs - A Global Market Perspective" report to their offering.
[More]
18. November 2009 01:46
MD Alliance International strongly urges all smokers to participate in the Great American Smokeout on November 19 to save their eyes and protect their vision from the debilitating effects of macular degeneration.
[More]
18. November 2009 01:41
A new study that examines the value of maternal blood biomarkers will help identify and monitor patients at risk of developing preeclampsia and is set to change the way expectant mothers are cared for in prenatal clinics around the world.
[More]
18. November 2009 00:13
Bayer's CONTOUR® USB meter, the first blood glucose monitor that connects directly to a PC or MAC -- providing users with instant access to information and trends about their blood sugar levels -- is now available for purchase through Walgreens online pharmacy and will soon also be available online through CVS and Walmart.
[More]
e1cfb415-d8ad-4180-ad4b-590b11039c44|0|.0
Posted in: Device / Technology News
Tags: Acetaminophen, Ascorbic Acid, Blindness, CDC, Diabetes, Education, Gestational Diabetes, Glucose Metabolism, Insulin, Juvenile Diabetes, Kidney Disease, Metabolism, Nutrition, Obesity, Stroke, Type 1 Diabetes, Type 2 Diabetes
16. November 2009 04:19
An Orange County Superior Court Judge has certified a class action against Abbott Medical Optics, Inc., on behalf of all California consumers who purchased a contact lens solution the Centers for Disease Control have linked to a parasitic infection that can cause blindness or the complete loss of an eye.
[More]
16. November 2009 02:29
Columbia University Medical Center will present the 2009 Naomi Berrie Awards to a nationally recognized diabetes researcher, and a promising young investigator, for their outstanding achievements in diabetes research.
[More]
a2734d01-5009-4133-9fc6-c433f83c2bde|0|.0
Posted in: Medical Condition News
Tags: Blindness, Cancer, Carbohydrate, Cell, Cholesterol, Diabetes, Diabetes Mellitus, Education, Genetics, Glucose Metabolism, Hospital, Hypoglycemia, Insulin, Kidney Disease, Metabolism, Nursing, Obesity, Ophthalmology, Pediatrics, Physiology, Stem Cell, Type 1 Diabetes, Type 2 Diabetes
13. November 2009 05:52
Schepens Eye Research Institute scientists have found that--when tested in a driving simulator--patients with hemianopia (blindness in one half of the visual field in both eyes) have significantly more difficulty detecting pedestrians (on their blind side) than normally sighted people. These results, published in the November 2009 issue of Investigative Ophthalmology and Visual Science, fly in the face of some recent on-road studies that have found most people with hemianopia safe to drive.
[More]
12. November 2009 03:50
ORBIS Canada, a non-profit global development organization dedicated to saving sight worldwide, is launching a series of holiday cards available for purchase this season. Proceeds of these cards will be used to build ORBIS Kids Sight treatment centres in the developing world.
[More]
10. November 2009 03:54
As many as 10 million people around the world suffer from cataracts. Thomas Kohnen of the Goethe University in Frankfurt and his coauthors discuss cataract surgery with the implantation of an artificial lens in the current issue of Deutsches -rzteblatt International (Dtsch Arztebl Int 2009; 106[43]: 695).
[More]
9. November 2009 08:31
Compugen Ltd. announced today the discovery and experimental confirmation of a genetic biomarker, CGEN-40001 for predisposition to type 2 diabetes, the most common form of diabetes.
[More]
2d5783e0-0e02-48a9-96c7-601313114c3f|0|.0
Posted in: Medical Science News | Medical Condition News
Tags: Atherosclerosis, Biomarker, Biotechnology, Blindness, Blood Vessel, Diabetes, Diabetes Mellitus, Diet, DNA, Insulin, Insulin Resistance, Type 2 Diabetes
7. November 2009 02:10
The scientific ability to quickly and accurately identify species through DNA "barcoding" is being embraced and applied by a growing legion of global authorities - from medical and agricultural researchers to police and customs authorities to palaeontologists and others.
[More]